Blinatumomab (MT103)

Blinatumomab · Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Blinatumomab (MT103), covering 2015-01-16 to 2015-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL [Phase 1]